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Jagged1 is the Major Regulator of Notch-
Dependent Cell Fate in Proximal Airways
Shubing Zhang,1 Amanda J. Loch,2 Freddy Radtke,3 Sean E. Egan,2 and Keli Xu1,4*
Background: The Notch signaling pathway plays complex roles in developing lungs, including regulation
of proximodistal fates, airway cell specification and differentiation. However, the specific Notch-mediated
signals involved in lung development remain unclear. Results: Here we report that Jagged1 is expressed
in a subset of bronchial and bronchiolar epithelial cells, where it controls proximal airway cell fate and
differentiation. In agreement with previous studies involving disruption of all Notch signaling, we found
that deletion of Jagged1 in airway epithelium increased the number of ciliated cells at the expense of
Clara cells, a phenotype associated with downregulation of Hes1. Deletion of Jagged1 also led to an
increased number of pulmonary neuroendocrine cells (PNEC), suggesting that Jagged1/Notch signaling
inhibits PNEC cell fate. As expected, Jagged1 deletion did not affect alveolar cell differentiation, although
alveolar septation was impaired, likely an indirect effect of proximal airway defects. Finally, in the post-
natal lung, Jagged1 deletion induced mucous metaplasia, accompanied by downregulation of Hes1 and
Hes5. Conclusions: Our results demonstrate that Jagged1-mediated Notch signaling regulates multiple
cell fate decisions as well as differentiation in the respiratory system to coordinate lung development and
to maintain a balance of airway cell types in adult life. Developmental Dynamics 242:678–686, 2013. VC 2013
Wiley Periodicals, Inc.
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Key Findings:
 Jagged1 regulates airway cell fate decision in the developing lung.
 Jagged1 prevents mucous metaplasia in the postnatal lung.
 Jagged1 influences alveologenesis.
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INTRODUCTION
Development of the mammalian respi-
ratory system requires coordinated dif-
ferentiation of multiple cell types that
form conducting airways and alveoli,
vasculature, as well as interstitial
tissue. The Notch signaling pathway
controls cell fate specification, differen-
tiation, proliferation, as well as
apoptosis during development. Notch
genes encode transmembrane recep-
tors that interact with membrane-
bound DSL ligands of the Delta and
Serrate/Jagged families. There are
four Notch receptors (Notch1, 2, 3, 4)
and five DSL ligands (Dll1, 3, 4, and
Jagged1, 2) in mammals. Notch recep-
tors and ligands, as well as Notch
signaling modulators, are broadly
expressed in developing lungs (Post
et al., 2000; Kong et al., 2004; K. Xu
et al., 2010), suggesting that Notch sig-
naling may play a critical role(s) in
lung development. Indeed, Notch sig-
naling has been shown to promote
proximal cell fates during early lung
morphogenesis. In this regard, Notch
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controls the balance of neuroendocrine
versus non-neuroendocrine and cili-
ated versus secretory cell types in the
developing airways, as well as to
prevent mucous metaplasia in the
postnatal lung (Ito et al., 2000; Shan
et al., 2007; Tsao et al., 2008, 2009,
2011; Guseh et al., 2009; Morimoto
et al., 2010, 2012). Recently, Notch was
found to control differentiation of
basally located adult airway stem cells
(Rock et al., 2011). In the distal lung,
Notch signaling is dispensable for alve-
olar epithelial differentiation and ec-
topic expression of constitutively active
Notch1 or Notch3 inhibits differentia-
tion and maturation of alveolar epithe-
lium (Dang et al., 2003; Guseh et al.,
2009). Despite this, Lfng-dependent
Notch signaling is required for alveolo-
genesis, likely through its effect on
Notch-dependent myofibroblast differ-
entiation (K. Xu et al., 2010). Thus,
Notch plays multiple roles and func-
tions at different stages of pulmonary
development. While Notch2 appears to
be the primary receptor for regulating
the Clara/ciliated cell decision and
Notch1, 2, and 3 function redundantly
to repress NE specification (Morimoto
et al., 2012), it is not known which
ligand(s) is involved. Here we report
that Jagged1 is highly expressed in
proximal airways. Spatial-temporal de-
letion of Jagged1 in the airway epithe-
lium during mouse embryonic
development causes altered cell fate
specification with an excess of PNEC,
as well as ciliated and mucosal cells, at
the expense of Clara cells. Inactivation
of Jagged1 also resulted in defective
alveologenesis in the distal lung. Thus,
Jagged1 functions during lung devel-
opment to control Notch-dependent dif-
ferentiation of most airway cell types.
RESULTS
Dynamic Expression of
Jagged1 in the Developing
Lung
We previously showed that Jagged1 is
broadly expressed in proximal airway
epithelial cells during the canalicular
stage (E16.5–E17.5) of mouse lung de-
velopment, whereas expression of
Dll1 is restricted to the pulmonary
neuroendocrine cells (K. Xu et al.,
2010). Here we further investigated
expression of Jagged1 throughout
mouse lung development by monitor-
ing b-Gal in Jagged1b-Geo/1 knock-in
mice (K. Xu et al., 2010). At embry-
onic day 13.5 (E13.5), b-Gal activity
was mostly restricted to mesenchyme
and a few scattered airway epithelial
cells. This expression persists
through E14.5, with positive cells
mostly found surrounding airway epi-
thelium (Fig. 1A,B). Immunofluores-
cence double staining showed co-
localization of Jagged1 with the endo-
thelial cell marker CD31, and in some
mesenchymal cells, with smooth mus-
cle actin a (Sma) (Fig. 1I,J). At E15.5,
b-Gal expression remained high in
mesenchymal cells immediately adja-
cent to conducting airways, but was
not seen in distal buds. Indeed, b-Gal-
positive cells were present in blood
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Fig. 1. Expression of Jagged1 in the developing lung. A–H: Representative photomicrographs of X-galactosidase (X-gal) staining in lung sections
from Jag1b-Geo/1 mice at the indicated developmental stages. Double staining of X-gal (stained in blue) and anti-Mash1 (stained in brown) are
shown in E. Neuroepithelial bodies (NEB) are indicated by arrowheads in E and shown in high-magnification image (inset in E). I–L: Immunofluores-
cence double staining of Jagged1 and smooth muscle actin-a (Sma) (I,K), Jagged1 and CD31 (J,L). Arrows point to cells showing co-staining of
Jag1 and Sma (I), Jage1 and CD31 (J). *Indicates autofluorescence in red blood cells. Scale bars¼ 50 mm in A–H and 10 mm in I–L.
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vessels but not in airway epithelium
(Fig. 1C). By E16.5, reporter expres-
sion turned on in bronchial and bron-
chiolar epithelium (Fig. 1D). At this
stage, Jagged1 expressers are
thought to be ciliated cells, juxtaposed
with Notch1-expressing Clara cells
(Tsao et al., 2009). Interestingly, X-gal
staining is not seen in cells immedi-
ately adjacent to neuroendocrine cells
of the neuroepithelial body (NEB)
(Fig. 1E, inset). Clara cells associated
with fetal NEBs (also called SPNC/
Clara-like cells) represent a distinct
set of progenitor cells that can self-
renew or give rise to Clara and cili-
ated cells in the adult lung (Guha
et al., 2012; Morimoto et al., 2012).
Notably, SPNC/Clara-like cells, which
express Notch1, Notch3, and probably
Notch2, and directly contact Dll1-
expressing PNECs (Ito et al., 2000; K.
Xu et al., 2010; Guha et al., 2012;
Morimoto et al., 2012), may also con-
tact Jagged1-expressing cells at the
border of the NEB. Double staining
was also used to test for expression of
Jagged1 in vascular cells. High-level
Jagged1 expression co-localized with
CD31, while low-level Jagged1 immu-
noreactivity was detected in smooth
muscle cells (Fig. 1K,L). During the
saccular stage of lung development
(E18.5 to postnatal day 5), b-Gal ac-
tivity was very weak or undetectable
in the distal lung, while vascular
smooth muscle cells and endothelial
cells showed robust staining. This
pattern of Jagged1 expression contin-
ued beyond birth and into adulthood
(Fig. 1F–H). We also detected Jagged1
expression by immunohistochemistry,
confirming our b-Gal gene-reporter-
based expression data (Fig. 2A). Thus,
Jagged1 expression in the developing
lung is dynamic, switching from mes-
enchymal cells to airway epithelium.
The most prominent expression
domain seen in airway epithelium
started at approximately E16.5
suggesting that Jagged1 may play an
important role(s) in proximal airway
development. Since multiple Notch
receptors are expressed in developing
airway cells, and in many cases
these cells are in direct contact
with Jagged1-expressing neighbors,
Jagged1-dependent Notch signaling
could regulate cell fate specification
and differentiation of multiple airway
cell types.
Jagged1 Mutation Causes
Altered Cell Fate
Specification in Proximal
Airways
To define the function of epithelial-
expressed Jagged1 in developing
lungs, we used the Spc-rtTA; Tet-O-
Cre airway-specific and inducible bi-
transgenic system (Mancini et al.,
2005; Perl et al., 2002). The Spc pro-
moter drives transgene expression
specifically in lung endoderm, first in
progenitor cells of primary lung buds,
and later at higher levels in type II al-
veolar cells of the distal lung (Okubo
and Hogan, 2004). Upon systemic
administration of a tetracycline ana-
log, doxycycline (Dox), the rtTA/Dox
complex activates expression of Cre
recombinase, which can trigger dele-
tion of Jagged1 exclusively in airway
epithelial cells of Jag1flox/flox; Spc-
rtTA; Tet-O-Cre triple transgenic mice
(hereafter referred to as Jag1cKO). We
treated pregnant females with Dox
from E7.5 to E17.5 so that Jagged1
would be deleted in airway cells of
Jag1cKO embryos. Indeed, anti-
Jagged1 immunostaining showed
decreased expression in proximal air-
ways, but not in arteries of E17.5
Jag1cKO mutant lungs (Fig. 2A,B).
The decreased level of Jagged1 was
confirmed by real-time RT-PCR (Fig.
3A,B). We next examined cell fate and
differentiation in proximal airways of
E17.5 Jag1cKO lungs by staining for
molecular markers of each cell type.
Compared to Jag1flox/flox; Spc-rtTA
controls, the Jag1cKO lung contained
far fewer secretory Clara cells
(stained positive for CC10) in bronchi
and bronchioles (Fig. 2C,D,M). In con-
trast, deletion of Jagged1 caused an
increase in the number of ciliated
cells (marked by b-tubulin) in proxi-
mal airways (Fig. 2E,F,M). Thus,
Jagged1 controls the balance between
secretory and ciliated cells in the
developing airway. Interestingly, this
phenotype is similar to that seen in
knockouts for Rbpjj or Pofut1, which
completely disrupt all canonical
Notch signaling, as well as in the
Notch2 mutant (Tsao et al., 2009;
Morimoto et al., 2012). In developing
airways, neuroendocrine (NE) differ-
entiation depends on basic helix-loop-
helix (bHLH) transcription factors. In
this context, Dll1-Notch signaling is
thought to regulate the NE versus
non-NE cell fate decision (Ito et al.,
2000). We, therefore, analyzed pulmo-
nary neuroendocrine cell (PNEC) dif-
ferentiation in Jag1cKO mutants
using anti-Mash1/Ascl1 and anti-
CGRP immunostaining (Fig. 2G–L).
Jag1cKO lungs showed a modest
increase in the number of NEBs
located within bronchi/bronchioles
while the number of PNECs per NEB
was not affected. In contrast, there
was a significant increase in the num-
ber of CGRPþ cells in distal lungs of
Jag1cKO mice (Fig. 2M). This
increased number of PNECs reveal
that Jagged1 is involved in regulating
NE versus non-NE cell fate in devel-
oping airways, likely through induc-
tion of Hes1, a bHLH transcription
factor and downstream target of ca-
nonical Notch signaling (Ito et al.,
2000; Morimoto et al., 2012). Indeed,
a survey of gene expression at E17.5
by quantitative RT-PCR showed that
Hes1 is the most downregulated gene
among selected Notch signaling path-
way targets in Jag1cKOmutant lungs
(Fig. 3A). In addition, the nuclear
Hes1 seen in control airways is barely
detectable in Jag1cKO mutants (Fig.
3C,D).
Despite an imbalance in proximal
airway cell types, the vast majority
of Jag1cKO mice survived into adult-
hood. We next examined the balance
of cell types in conducting airways of
adult Jag1cKO lungs. A decreased
percentage of Clara cells persisted in
adult mutant lungs (Fig. 4A,B,G).
Interestingly, anti-Muc5AC immu-
nostaining and Alcian Blue staining
showed that Jag1cKO mutant mice
developed mucous metaplasia in the
conducting airway, starting from 6
weeks of age (Fig. 4C–G). Thus, dele-
tion of Jagged1 caused an increased
production of goblet cells at the
expense of Clara cells. This result is
in agreement with the finding that
Notch signaling through Hes5
restricts mucin gene expression
(Tsao et al., 2011). Indeed, quantita-
tive RT-PCR revealed decreased
expression of Hes1 and Hes5 in
the Jag1cKO mutant lung at 4 weeks
after birth (Fig. 3B). When com-
pared to Pofut1 conditional knock-
outs, using a Tgfb3-Cre deleter
(Tsao et al., 2011), the mucous meta-
plasia observed in Jag1cKOmutant
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mice appeared less severe. This may
well be due to relatively low
efficiency of Cre induction in the
bi-transgenic system, activated in
embryos via placental transfer of
doxycycline. Some pulmonary
progenitor cells may escape Dox-
induced deletion of Jagged1 during
embryonic development, and give
rise to progeny cells carrying wild-
type Jagged1 in conducting airways
of adult lung.
Defective Alveolar Septation
in Jag1cKO Mutant Lungs
By the canalicular/early saccular
stage of lung development, Jagged1
expression is confined to bronchial
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Fig. 2. Deletion of Jagged1 in lung epithelium disrupts the balance of proximal airway cell types. A–L: Representative photomicrographs of
immunohistochemistry for Jagged1, CC10, b-tubulin, Mash1, and CGRP in E17.5 lung sections of Jag1flox/flox; Spc-rtTA (A,C,E,G,I,K) and Jag1cKO
mice (B,D,F,H,J,L) treated with Doxycycline from E7.5 to E17.5. CGRP staining in the distal lung are shown in K and L. Br: bronchiole; Ar: artery.
Arrows point to neuroepithelial bodies (NEB) in G–J. Scale bars¼ 50 mm. M: Quantification of labeled cells. CC10þ and b-tubulinþ cells are quanti-
fied and normalized as percentage of total cells in bronchi/bronchioles. NEBs are quantified in 20 magnification photographs (n¼ 13) of proximal
airways. Mash1þ PNECs are quantified per NEB. Numbers of CGRPþ cells in the distal lung are quantified in 20 magnification photographs
(n¼ 12). Control mice included Jag1flox/flox; Spc-rtTA and Jag1flox/flox; Tet-O-Cre. Data are presented as mean6 standard deviation derived from at
least three animals of each group. P values are calculated using the Student’s t-test.
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and bronchiolar epithelia, and dele-
tion of Jagged1 caused an imbalance
of cell types within proximal airways.
Next, we examined distal lung devel-
opment in the Jag1cKO mutant mice.
Immunostaining of E17.5 lung sec-
tions from Jag1cKO mutants showed
grossly normal expression of type II
alveolar cell (SPC) and type I alveolar
cell (T1a=podoplanin) markers. While
Jag1cKO mutants appear to have
slightly thicker alveolar walls, the
percentage of SPCþ type II cells (out
of the total number of distal lung
cells) is similar in mutant (15%) and
control (14%) lungs (Fig. 5A,B). The
continuous lining of T1aþ cells on the
apical side of each alveolus suggests
that proper differentiation and matu-
ration of type I cells occurs in mutant
lungs (Fig. 5C,D). Capillaries are an
integral component of alveoli. Given
that Notch signaling controls vascular
development (Herbert and Stainier,
2011), we examined the capillary net-
work in Jag1cKO mutant lungs. As
shown in Figure 5E,F, anti-CD31 im-
munostaining revealed no obvious
abnormalities in microvasculature.
Thus, Jagged1-mediated Notch acti-
vation is dispensable for alveolar epi-
thelial cell differentiation, and distal
lung development seems to proceed
normally in prenatal Jag1cKO mutant
lungs. However, in 6 out of 9 Jag1cKO
mutants examined, alveolar septation
was disrupted to some degree. For
instance, one week after birth, some
mutant lungs showed impaired alveo-
larization, with relatively large alveo-
lar saccules and a decreased number
of growing septae. By 3 weeks of age,
the majority of mutant lungs exhib-
ited an emphysema-like phenotype
due to largely failed secondary septa-
tion of alveoli (Fig. 5K–P, U).
PDGFRa signaling controls myofibro-
blast differentiation, which is
required for alveolarization in the dis-
tal lung (Bostrom et al., 1996; Lindahl
et al., 1997; Kimani et al., 2009). We
found similar staining intensity and
distribution of PDGFRa and smooth
muscle actin-a, markers for myofibro-
blast progenitors and differentiated
myofibroblasts, in Jag1cKO and con-
trol lungs (Fig. 5G–J), indicating that
deletion of Jagged1 had no obvious
effect on myofibroblast differentia-
tion. To rule out the possibility that
Dox-rtTA toxicity caused alveolar
defects in Jag1cKO mice (Morimoto
and Kopan, 2009), we conducted addi-
tional loss-of-Jag1 experiments.
When Dox were fed from E7.5 to
E15.5, Jag1cKO mutants still showed
defective alveolar septation, while
Jag1flox/flox; Spc-rtTA controls
appeared normal (Fig. 5Q,R). We also
examined whether Dox-rtTA toxicity
interferes with alveologenesis by feed-
ing Dox from E16.5 to postnatal day
10. Under these conditions, all three
Jag1flox/flox; Spc-rtTA lungs examined
by H&E staining showed normal alve-
olar structure (Fig. 5S,T,U). We con-
clude that Dox-rtTA toxicity does not
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Fig. 3. Altered expression of Notch signaling pathway genes in Jag1cKO mutant lungs. A,B:
Real-time RT-PCR of Jag1, Jag2, Dll1, and selected Notch target genes in Jag1flox/flox; Spc-rtTA
and Jag1cKO mutant lungs at E17.5 (A) and postnatal day 28 (B). Animals were treated with Dox
the same as in Figure 2. Data are presented as mean6 standard deviation (n¼ 3 per group). P
values are calculated using the Student’s t-test. *P< 0.05, **P< 0.005, ***P< 0.0005. C,D: Rep-
resentative photomicrographs of anti-Hes1 immunostaining in E17.5 lung sections of Jag1flox/flox;
Spc-rtTA (C) and Jag1cKO mice (D). Br: bronchiole; Ar: artery. Scale bars¼ 50 mm.
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contribute significantly to alveolar
defects observed in the Jag1cKO
mutants. Perhaps our mice were less
susceptible to Dox-rtTA toxicity
because they were on a mixed genetic
background that differed from the
background tested by Morimoto and
Kopan. Interestingly, deletion of
Jagged1 in the alveolar epithelial
cells only (by administration of Dox
starting at E16.5 or E17.5) had no
effect on alveolar development (Fig.
5S,T,U and data not shown), indicat-
ing that the Jagged1-mediated signal
that directly or indirectly influences
alveolarization is likely coming from
proximal airway cells.
DISCUSSION
Multiple Notch receptors and ligands
are expressed in the developing lung,
and canonical Notch signaling has
been shown to regulate airway line-
age specification and differentiation.
Here we show that Jagged1 is
required for correctly balanced cell
fate specification in conducting air-
ways. Interestingly, Jagged1 appears
to regulate multiple cell fate decisions
in the lung epithelial hierarchy (sum-
marized in Fig. 6). PNEC is one of the
first specified cell types during airway
morphogenesis. Dll1-mediated
“lateral inhibition” is thought to con-
trol the NE versus non-NE cell fate
balance (Ito et al., 2000). However, we
report here that deletion of Jagged1
in non-NE cells caused an increased
number of NE cells to form. Since
Jagged1 is expressed in cells juxta-
posed to SPNC cells, it is likely that
Jagged1 can activate Notch in SPNC
cells and prevent them from adopting
an NE fate. Currently, we do not have
a clear explanation for why the
Jag1cKO shows ectopic CGRPþ cells in
the distal lung. Also, during subse-
quent airway epithelial development,
Jagged1 is expressed in ciliated cells,
while Notch1 and Hes1 are highly
expressed in non-ciliated cells, often
in an alternating pattern (Tsao et al.,
2009). Here we report that deletion of
Jagged1 caused excessive ciliated
cells to form at the expense of Clara
cells, supporting a lateral inhibition
model whereby Jagged1 in ciliated
cells activates Notch receptors in
neighboring cells and thereby blocks
a default ciliated fate (Morimoto
et al., 2010, 2012). In the distal lung,
deletion of Jag1 had no effect on dif-
ferentiation and maturation of alveo-
lar epithelial cells. However, Jag1cKO
lungs showed defective alveolar sep-
tation. Unlike Lfng null mice,
Jag1cKO mice show timely differentia-
tion of myofibroblasts, and a less
severe alveolar phenotype. Given that
Fringe facilitates Delta-mediated
Notch activation and inhibits Jagged/
Serrate-mediated Notch signaling
(Haines and Irvine, 2003), loss of Lfng
and loss of Jag1 would represent very
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Fig. 4. Decreased number of Clara cells and mucous metaplasia in adult Jag1cKO mutant
lungs. A–F: Representative photomicrographs of anti-CC10, anti-Muc5AC immunostaining, and
Alcian Blue staining in lung sections of Jag1flox/flox; Spc-rtTA (A,C,E) and Jag1cKO (B,D,F) mice at
6 months of age. Animals were treated with Dox the same as in Figure 2. Scale bars¼ 50 mm.
G: Quantification of the labeled cells. Positively stained cells are quantified and normalized as
percentage of total cells in the bronchi. Data are presented as mean6 standard deviation
derived from at least two animals of each genotype. P values are calculated using the Student’s
t-test. *P< 0.05.
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Fig. 5. Deletion of Jagged1 in lung epithelium results in defective alveolarization despite grossly normal differentiation of distal lung cells. A–J:
Representative photomicrographs of anti-SPC (A,B), anti-T1a (C,D), anti-CD31 (E,F), anti-PDGFRa (G,H) immunostaining in the Jag1flox/flox; Spc-
rtTA and Jag1cKO lung sections at E17.5, and anti-smooth muscle actin-a (SMA) staining at postnatal day 7 (I,J). Dox was administered from em-
bryonic day 7.5 to 17.5. K–P: Representative H&E-stained lung sections from Jag1flox/flox; Spc-rtTA (K,M,O) and Jag1cKO (L,N,P) mice at 1 week
(K,L), 3 weeks (M,N), and 7 weeks (O,P) old. Animals were treated with Dox from E7.5 to E17.5. Q,R: Representative H&E staining of lung sections
from Jag1flox/flox; Spc-rtTA (Q) and Jag1cKO (R) mice at 3 weeks of age with Dox treatment from embryonic day 7.5 to 15.5. S,T: Representative
H&E staining of lung sections from Jag1flox/flox; Spc-rtTA (S) and Jag1cKO (T) mice at 3 weeks of age with Dox treatment from embryonic day 16.5
to postnatal day 10. U: Mean linear intercepts measured in lung sections from adult mice with Dox treatment of E7.5–E17.5, E7.5–E15.5, and
E16.5–PN10. Values are means6 s.d. P values are calculated using the Student’s t-test. Scale bars¼ 50 mm in A–J and 100 mm in K–T.
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different perturbations of the system,
likely explaining the fairly different
defect in alveolar development
observed in each mutant. Intrigu-
ingly, Lfng is highly expressed in
PNECs while Jagged1 expression is
found surrounding the NEB. A previ-
ous report on NeuroD function during
lung development suggested an inti-
mate connection between the neuro-
endocrine compartment and distal
lung development (Neptune et al.,
2008). In this context, both Lfng and
Jagged1 may well function within the
NEB niche to send signals for proper
distal lung morphogenesis.
In the postnatal lung, Notch signal-
ing has been shown to prevent mu-
cous metaplasia through bHLH
transcription repressor Hes5 (Tsao
et al., 2011). We observed an
increased number of goblet cells in
adult Jag1cKO lungs, suggesting that
Jagged1 contributes to suppression of
goblet cell fate and mucin production.
It would be interesting to determine
whether Jagged1/Notch signaling
functions to suppress transdifferen-
tiation in adults, or if it controls lung
fate specification only via lateral inhi-
bition during development. Interest-
ingly, deletion of Jagged1 caused
decreased expression of Dll1, as well
as two Notch target genes, Hes1 and
Hes5, in adult lung tissue (Fig. 3D).
Down-regulation of notch pathway
genes, most significantly Dll1 and
Hes5, was previously reported in
human airway epithelium associated
with smoking and chronic obstructive
pulmonary disease (COPD) (Tilley
et al., 2009). Our results further sup-
port the notion that Notch signaling
may well actively maintain a balance
of cell types lining conducting airways
to prevent COPD in adult life.
EXPERIMENTAL
PROCEDURES
Mouse Experiments
Mice were housed under standard
condition and all animal procedures
were approved by the Institutional
Animal Care and Use Committee of
the University of Mississippi Medical
Center. Jagged1flox mice have been
described previously (Mancini et al.,
2005). To achieve deletion of Jagged1
in the pulmonary epithelium, we used
a tetracycline-inducible “Tet-On”
transgenic system including two
transgenic mouse lines, Spc-rtTA and
Tet-O-Cre (Perl et al., 2002). For the
deletion of Jagged1 throughout the
lung epithelium during development,
pregnant females were administered
with doxycycline-containing chow
(0.625 g/Kg; Harlan-Teklad, Madison,
WI) from day 7.5 to 17.5 of pregnancy.
For the deletion of Jagged1 in the dis-
tal lung epithelial cells only, doxycy-
cline diet was given from pregnant
day 17.5 to postnatal day 10.
Quantitative RT-PCR
Total RNA was prepared from lung
tissues of control and Jag1cKO mutant
mice using the RNeasy Mini Kit (Qia-
gen, Valencia, CA) and reverse-tran-
scribed using iScript cDNA Synthesis
Kit (Bio-Rad, Hercules, CA).
Quantitative RT-PCR was performed
on a BioRad CFX96 Real-Time Sys-
tem using the RT2 SYBR Green qPCR
Master Mixes (Qiagen). We used the
primer sequences for Jag1, Jag2,
Dll1, Hes1, Hes5, Hey1, Hey2, Ascl1,
and Cgrp as previously reported (J.
Xu et al., 2010; Tsao et al., 2011; Voro-
nova et al., 2011; Morimoto et al.,
2012). The relative abundance of
mRNA for each gene to GAPDH was
determined by the equation 2-DCT,
where DCT¼CTTested Gene - CTGAPDH.
Data were derived from three animals
per group (triple reactions for each
sample).
Tissue Preparation,
Histology, and Morphometry
Lung tissues at embryonic day 17.5
and postnatal day 7 were dissected
and fixed in 10% buffered neutral for-
malin overnight and subsequently em-
bedded in paraffin according to
standard procedures. For adult lung
tissues, inflation with 10% formalin at
a constant fluid pressure of 25 cm
H2O for 5 min was performed before
fixation and embedding, as previously
described (Braber et al., 2010). Five-
micrometer-thick sections were
stained with hematoxylin and eosin
(H&E). Representative images of H&E
staining were acquired with a Nikon
Eclipse 80i microscope. Mean linear
intercepts were measured as previ-
ously described (K. Xu et al., 2010).
X-Gal Staining
For X-gal staining, lung tissues were
fixed in 2.7% formaldehyde, 0.02%
Nonidet-P40 in PBS overnight,
washed and infused with 30% sucrose,
then embedded in OCT compound.
Ten-micrometer-thick cryosections
were stained with X-gal at 37

C for a
few hours to overnight. Stained sec-
tions were further counterstained with
eosin. In some experiments, lung tis-
sues were whole-mount stained with
X-gal, fixed in formalin, and embedded
for paraffin sections, then counter-
stained with neutral red.
Immunohistochemistry
Immunostaining of lung sections was
carried out as previously described
(K. Xu et al., 2010). Staining was
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s Fig. 6. Model for roles of Jagged1 in airway
epithelial cell differentiation. A: During prenatal
lung development, neuroendocrine (NE) ver-
sus Non-NE cell fate determination in the
proximal airway is controlled by Notch signal-
ing. In this context, both Jagged1 in cells
flanking the NEB and Dll1 in PNECs may acti-
vate Notch in SPNC cells to prevent them
from adopting NE fate. B: The cell fate deci-
sion between Clara and ciliated cells is medi-
ated by Jagged1-dependent lateral inhibition,
whereby Jagged1, expressed in ciliated cells,
activates Notch in neighboring cells to sup-
press ciliated fate and promote Clara cell dif-
ferentiation. C: In postnatal airways, Jagged1-
mediated Notch signaling in Clara cells
restricts goblet cell differentiation through
Hes5. See the text for details.
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performed on two sections per lung
from at least three animals for each
group. Presented are representative
photomicrographs. Primary antibod-
ies used for immunostaining were as
follows: Jagged1 (Santa Cruz, Santa
Cruz, CA: sc-6011, 1:100), Hes1
(Abcam, Cambridge, MA; ab71559,
1:200), smooth muscle actin-a
(Abcam, ab5694, 1:400), CD31
(Abcam, ab28364, 1:50), PDGFRa
(Santa Cruz, sc-338, 1:100), CC10
(Santa Cruz, sc-25555, 1:200), SPC
(Santa Cruz, sc-13979, 1:200), CGRP
(Santa Cruz, sc-8857, 1:150), Muc5AC
(Santa Cruz, sc-21701, 1:50), T1a
(University of Iowa, DSHB, Iowa City,
IA; 1:1,000), Mash1 (BD Biosciences,
San Jose, CA: 556604, 1:50), and b-
tubulin (Sigma, St. Louis, MO; T7941,
1:200).
Statistics
All data are presented as mean-
6 standard deviation. Statistical
analysis was performed using the
two-tailed Student’s t-test. P value of
0.05 or less was considered
significant.
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